Rick joins MicroCal from Isis Pharmaceuticals where he served as Vice President of Business Development for Isis and President of Isis’ functional genomics division, GeneTrove. GeneTrove established research collaborations and licensing agreements with most leading pharmaceutical companies and many biotechnology companies to apply GeneTrove’s proprietary technology to their drug discovery research programs.
Before joining Isis, Rick spent five years with Discovery Partners International (DPII), a provider of scientific tools, systems and research services to the pharmaceutical industry for their new drug discovery and development efforts. At DPII Rick was President of IRORI, one of their operating companies. IRORI provides automated chemical synthesis systems and services to drug discovery laboratories. Prior to this, Rick spent 17 years in various capacities with companies involved in laboratory automation and analytical instruments used by life scientists in industry and academia.
Rick received his BS in Chemistry from Massachusetts State College in North Adams, MA and his Ph.D. in Chemistry from the University of Massachusetts, Amherst.
“I am particularly excited to be joining this well-regarded company at this time in their history. The number of new innovations and products we expect to announce as well the opportunity to further expand our reach to new customers and applications is extremely promising” Rick said during his recent introduction to the team members at MicroCal. “I truly look forward to working with this group of talented and dedicated people to continue the impressive growth of MicroCal in its service to life-scientists around the globe.”